Critter Controllers

Not All Animals Are The Cutest

Category: Biotechnology

04 May 2019

Marc Beer And His New Role Of Chairman Of The Board At LumeN XT  0

The Boston-based surgical device company LumeN XT announced at the beginning of April the addition of Marc Beer to the company’s team, with him taking on the role of LumeNXT’s Chairman of the Board. Beer brings to the table more than 25 years of experience in areas of development and commercialization in the field of pharmaceuticals, devices, biotechnology, and diagnostics.

 

About LumeN XT And Its Illumination Platform

 

LumeN XT is a private company, considered to be a pioneer when it comes to the use of intracavity LED (light emitting diode) illumination. The company focuses on the development of surgical illumination product line in order to help with surgeries that are minimally invasive. LumeNXT’s illumination platform is used as a heat reduction mechanism designed to provide various advantages, such as improved surgical precision, increased workflow efficiency and improved safety via enhanced visualization. Surgeons who are using targeted illumination have pointed out that the, when compared to traditional techniques, the technology enhances flexibility, precision, and visualization.

 

Taking On The Role Of Chairman of the Board

 

The seasoned pharmaceuticals executive talked about his new role of Chairman of the Board and about the company in general. Beer stated this pride in working with ELemeNT’s group of surgeon and engineers, describing them as being accomplished and dedicated. He also noted that they are responsible with advancing the field of surgical illumination by using LumeNXT’s technology towards safely performing surgeries. In addition, he believes that the importance of the company’s platform will increase once more surgeries will be performed featuring minimally invasive approaches.

 

Paul Rhyne, the co-founder of LumeN XT also talked about the new addition to the team, noting that Beer has had high levels of success in working with multiple startup companies, and that his experience is highly valued at LumeN XT.

 

About Marc Beer

 

Besides his new role of Chairman of the Board at LumeN XT, Marc Beer also dedicates time to his own company, Renovia, Inc., which he co-founded in August 2016. The company’s goal is to find and deliver digital therapeutic and diagnostic devices to women who suffer from pelvic floor disorders. Prior to LumeN XT and Renovia, Marc Beer worked for a number of companies within the biotechnology industry, making a name for himself and earning a reputation, with a career that spans over more than 25 years.

 

He worked for Minerva Neurosciences Inc. as the Founding Chairman, Erytech Pharma as a member of the Board of Directors, and was also part of Good Start Genetics, Inc. serving as Founding Chairman. In addition, Beer was the Founding CEO of ViaCell, from 2000 to 2007. Under his leadership, the company saw rapid growth, having over 300 employees, going public in 2005, before being ultimately acquired by PerkinElmer in 2007. Learn more: https://renoviainc.com/leadership/

19 Apr 2019

Dr. Dov Rand and His Specialty  0

Dr. Dov Rand has a range of specialties and sub-specialties in the medical field. At times, it can be a bit cumbersome to keep up with them all. However, this is not the case with Dr. Dov Rand. He has done all that is in his power to ensure that they get to maintain a healthy and happy life to last them through their lifetime (Drdovrand).

What’s more? He ensures that they can all learn the basics and the different branches of the medical field such that whenever they need medical care, they know what to do and where to seek assistance.

Dr. Dove Rand’s physical medicine and rehabilitation specialty focus mainly on improving his patients’ life quality and enhancing their functional ability, unlike most medical practitioners in that field that primarily focus on issues concerning muscles, ligaments, bones and the nervous system.

Dr. Dov Rand uses some philosophies resulting from his life-long interest in attaining knowledge in the medical field. He is very passionate about medicine and he is always on the lookout for discoveries about the same. He has dedicated his life into doing researches and testing treatments to ensure that patients get the highest quality and latest treatments. Dr. Rand uses bioidentical hormone therapy on his patients. He also writes articles and journals about new treatments, and he has ensured that only the medications that go to his journal are prescribed to his patients.

Dr. Dov Rand attended Rutgers University for his undergrad and Howard University for medical school. He got an intern at Saint Barnabas Medical Center and later at Albert Einstein Medical Center. Regardless of all these knowledge in medicine and the time he spent gaining it he is still very passionate about literature and scientific studies. He also loves discussing ideas with his colleagues and going for conferences.

These activities have helped Dr. Dov Rand and his patients to gain access to the highest quality and up to date treatment and information. Impressive, right? Not to mention that he has received several awards for his fantastic job in researches that have resulted in medical innovations and his dedication to helping people live healthy lives.

Find more information about Dr. Rand´s medical method at https://www.menundermicroscope.com/how-dr-dov-rand-helps-men-with-erectile-dysfunction/

05 Mar 2019

“Marc Beer succeeds once more in raising funds for women’s health through Series B round “  0

Starting a company in today’s competitive biotech industry deserves a high degree of skill to do research, financing and the approval for new therapies from the FDA, Food and Drug Administration. Renovia Inc. is one of the companies that started through the mentioned processes in August 2016 during its foundation by Marc Beer. The company that operates from Boston raised funds through Series A round and used the money to finance the technology of fighting pelvic floor disorder from another company. The problem faces over 230 million women worldwide, but Renovia continues to look for ways of helping the affected women. Its first product to get approval from FDA was Leva device in April 2018.

 

Marc Beer successfully organized the series B funding that took place on August 21, 2018, that raised $32.3 million in equity and $10 million in venture funds making a total of $42.3 million. According to the company’s management, the funds would go into diagnostic analysis and development of four more products on top of leva device. The company also intends to upgrade its leva pelvic health digital system through the funds and cater for clinical experiments, corporate development, and improvement of the production system and launching of products. New York’s Perceptive Advisers is one of the Renovia’s business partners that stood with Renovia. Ascension Ventures that work from Missouri participated in the process, and Marc Beer thanked the two among other health companies supporting such health initiatives.

 

Apart from boosting the treatment and diagnostic systems, Renovia Inc. plans to use some of the funding to promote the leva device. Leva device comes with a Bluetooth and an app for generating coaching schedules, and real-time visualization. The primary functions of the invention are to control the linear optimized moving patterns and to sort out the weak leva plate muscles. Besides, the company would come up with more wearable devices and other innovative diagnostic materials and clinical procedures. The millions of women suffering from pelvic floor disorders undergo painful sessions of urinary incontinence, frequent urination, pain pressure, and problems of emptying the whole bladder after urination and painful intercourse.

 

Marc Beer points out that the new digital platform would help the patients’ access to more data covering the new methods of treatment, basic knowledge, and the way of lowering treatment costs. Marc Beer has the expertise of 25 years in sales, development, biotechnology, and management having worked in recognized companies like Viacell and Abbott laboratories. In Viatell, Marc worked in the control of the company, and he oversaw the overall study of the human cells to come out with the desired cures. His idea of starting Renovia was to help the women access quality care through the latest technology at affordable prices through the Leva Pelvic Digital Health System. Learn more: https://www.bizjournals.com/boston/news/2018/08/21/ex-aegerion-chief-beer-raises-42m-for-womens.html